BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 7,500,000 Value ($000) $4,622 Avg Close — Range —
Q1 2023
Shares 7,500,000 Value ($000) $4,794 Avg Close — Range —
Q4 2022
Shares 7,500,000 Value ($000) $2,909 Avg Close — Range —
Q3 2022
Shares 7,500,000 Value ($000) $3,316 Avg Close — Range —
Q2 2022
Shares 7,500,000 Value ($000) $3,354 Avg Close — Range —
Q1 2022
Shares 7,500,000 Value ($000) $3,619 Avg Close — Range —